BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2659598)

  • 1. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
    Yuh YS; Thompson EB
    J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
    Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.
    Zhou F; Medh RD; Thompson EB
    J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
    Thulasi R; Harbour DV; Thompson EB
    J Biol Chem; 1993 Aug; 268(24):18306-12. PubMed ID: 8394364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.
    Maroder M; Martinotti S; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
    Nucleic Acids Res; 1990 Mar; 18(5):1153-7. PubMed ID: 2320412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
    Medh RD; Wang A; Zhou F; Thompson EB
    Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of c-myc mRNA expression by steroid hormones in HTLV-I-infected T-cell line, KH-2.
    Koizumi T; Nakao Y; Kawanishi M; Maeda S; Sugiyama T; Fujita T
    Int J Cancer; 1989 Oct; 44(4):701-6. PubMed ID: 2793241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
    Goya L; Maiyar AC; Ge Y; Firestone GL
    Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementation between glucocorticoid receptor and lymphocytolysis in somatic cell hybrids of two glucocorticoid-resistant human leukemic clonal cell lines.
    Yuh YS; Thompson EB
    Somat Cell Mol Genet; 1987 Jan; 13(1):33-45. PubMed ID: 3468632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
    Ashraf J; Kunapuli S; Chilton D; Thompson EB
    J Steroid Biochem Mol Biol; 1991 May; 38(5):561-8. PubMed ID: 2039752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-myc oncogene is regulated independently of differentiation in myeloid cell lines.
    Roberts P; Jones M; Gale R; Thomas S; Tidman N; Linch D
    Leuk Res; 1989; 13(8):651-9. PubMed ID: 2507827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible suppression of c-myc expression in a human colon carcinoma line by the anticancer agent N-methylformamide.
    Chatterjee D; Mendelsohn A; Shank PR; Savarese TM
    Cancer Res; 1989 Jul; 49(14):3910-6. PubMed ID: 2660982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
    Liu Y; Zhang S; Tan Y
    Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells.
    Wood AC; Waters CM; Garner A; Hickman JA
    Br J Cancer; 1994 Apr; 69(4):663-9. PubMed ID: 8142255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of c-erbA proto-oncogene expression by glucocorticoid hormones in S49.1 lymphoma cells.
    Maroder M; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
    Biochim Biophys Acta; 1989 Nov; 1009(2):188-90. PubMed ID: 2553102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids.
    Brönnegård M; Andersson O; Edwall D; Lund J; Norstedt G; Carstedt-Duke J
    Mol Endocrinol; 1988 Aug; 2(8):732-9. PubMed ID: 2974926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification and overexpression of c-myc proto-oncogene correlate with the loss of glucocorticoid dependence in rodent cells transformed by human papillomavirus type 16.
    Crook T; Banks L; Smith K; Crawford L
    Mol Carcinog; 1989; 2(6):308-13. PubMed ID: 2482744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation.
    Rhee K; Bresnahan W; Hirai A; Hirai M; Thompson EA
    Cancer Res; 1995 Sep; 55(18):4188-95. PubMed ID: 7664296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.